Beraprost

Beraprost
Clinical data
Trade names	Dorner
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	B01AC19 (WHO) ;
Pharmacokinetic data
Bioavailability	50–70%
Metabolism	Unknown
Elimination half-life	35–40 minutes
Identifiers
	IUPAC name 4-{(1R,2R,3aS,8bS)-2-Hydroxy-1-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2,3,3a,8b-tetrahydro-1H-benzo[b]cyclopenta[d]furan-5-yl}butanoic acid;
CAS Number	88430-50-6 88475-69-8;
PubChem CID	6917951;
IUPHAR/BPS	1967;
ChemSpider	5293169 ;
UNII	35E3NJJ4O6;
ChEBI	CHEBI:135633;
ChEMBL	ChEMBL1207745 ;
CompTox Dashboard (EPA)	DTXSID7049136 ;
Chemical and physical data
Formula	C24H30O5
Molar mass	398.499 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C3=CC=CC(=C3O2)CCCC(=O)O)O)O;
	InChI InChI=1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/b13-12+/t15?,17-,19+,20+,21-,23-/m0/s1 ; Key:CTPOHARTNNSRSR-APJZLKAGSA-N ;
	(what is this?) (verify)

Beraprost is a pharmaceutical drug used in several Asian countries, including Japan and South Korea, as a vasodilator and antiplatelet agent. It is classified as a prostacyclin analog.

It has been studied for the treatment of pulmonary hypertension and for use in avoiding reperfusion injury.